Stanley D. Glick

Stan was a professor of pharmacology at Mount Sinai School of Medicine and chaired the pharmacology and neuroscience program at Albany Medical College. Dr. Glick’s major research interest focused on the neurobiology of drug addiction. His research was funded by the National Institute on Drug Abuse (NIDA) for forty years and he is a co-inventor of a novel group of agents (iboga alkaloid congeners) for treating drug addiction, including 18-methoxycoronaridine (18-MC). Dr. Glick has authored or co-authored over 450 experimental papers, reviews and abstracts, and has served on journal editorial boards and NIH advisory committees.